Skip to main content

Table 2 Characteristic of the validation cohort

From: Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis

 

SCC patients

ADC patients

Healthy control

p value (SCC/ADC)

Total

39

39

44

 

Gender

0.002a*

 Male

35

23

21

 < 0.001b*

 Female

4

16

23

0.380c

Age

47–85

31–84

29–58

 

Tumor stage

0.151a

 I

3

9

  

 II

5

2

  

 III

10

6

  

 IV

21

22

  
  1. Statistic tests are performed on aSCC versus ADC; bSCC versus Healthy control; cADC versus Healthy control. *represents p < 0.05